AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Zagars, GK Pollack, A
Citation: Gk. Zagars et A. Pollack, Radiotherapy for Stage II testicular seminoma, INT J RAD O, 51(3), 2001, pp. 643-649

Authors: Callister, MD Ballo, MT Pisters, PWT Patel, SR Feig, BW Pollock, RE Benjamin, RS Zagars, GK
Citation: Md. Callister et al., Epithelioid sarcoma: Results of conservative surgery and radiotherapy, INT J RAD O, 51(2), 2001, pp. 384-391

Authors: Zagars, GK Pollack, A von Eschenbach, AC
Citation: Gk. Zagars et al., Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer, UROLOGY, 58(2), 2001, pp. 233-239

Authors: Ballo, MT Zagars, GK Pisters, PWT Feig, BW Patel, SR Von Eschenbach, AC
Citation: Mt. Ballo et al., Spermatic cord sarcoma: Outcome, patterns of failure and management, J UROL, 166(4), 2001, pp. 1306-1310

Authors: Cormier, JN Patel, SR Herzog, CE Ballo, MT Burgess, MA Feig, BW Hunt, KK Raney, RB Zagars, GK Benjamin, RS Pisters, PWT
Citation: Jn. Cormier et al., Concurrent ifosfamide-based chemotherapy and irradiation - Analysis of treatment-related toxicity in 43 patients with sarcoma, CANCER, 92(6), 2001, pp. 1550-1555

Authors: Kelly, JF Pollack, A Zagars, GK
Citation: Jf. Kelly et al., Serum testosterone is not a correlate of prostate cancer lymph node involvement, but does predict biochemical failure for lymph node positive disease, UROL ONCOL, 5(2), 2000, pp. 78-84

Authors: Pollack, A Zagars, GK Smith, LG Lee, JJ von Eschenbach, AC Antolak, JA Starkschall, G Rosen, I
Citation: A. Pollack et al., Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer, J CL ONCOL, 18(23), 2000, pp. 3904-3911

Authors: Pollack, A Ashoori, F Sikes, C Joon, DL von Eschenbach, AC Zagars, GK Meistrich, ML
Citation: A. Pollack et al., The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions, INT J RAD O, 46(1), 2000, pp. 153-158

Authors: Chaney, AW Pollack, A Mcneese, MD Zagars, GK Pisters, PWT Pollock, RE Hunt, KK
Citation: Aw. Chaney et al., Primary treatment of cystosarcoma phyllodes of the breast, CANCER, 89(7), 2000, pp. 1502-1511

Authors: Ballo, MT Zagars, GK Pollack, A Pisters, PWT Pollock, RA
Citation: Mt. Ballo et al., Desmoid tumor: Prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy, J CL ONCOL, 17(1), 1999, pp. 158-167

Authors: Zagars, GK Pollack, A Smith, LG
Citation: Gk. Zagars et al., Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX/N0, M0) adenocarcinoma of the prostate, INT J RAD O, 44(4), 1999, pp. 809-819

Authors: Hanus, MC Zagars, GK Pollack, A
Citation: Mc. Hanus et al., Familial prostate cancer: Outcome following radiation therapy with or without adjuvant androgen ablation, INT J RAD O, 43(2), 1999, pp. 379-383

Authors: Khoo, VS Pollack, A Cowen, D Joon, DL Patel, N Terry, NHA Zagars, GK von Eschenbach, AC Meistrich, ML Troncoso, P
Citation: Vs. Khoo et al., Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy, PROSTATE, 41(3), 1999, pp. 166-172

Authors: Pollack, A Zagars, GK Rosen, II
Citation: A. Pollack et al., Prostate cancer treatment with radiotherapy: Maturing methods that minimize morbidity, SEMIN ONCOL, 26(2), 1999, pp. 150-161

Authors: Liebross, RH Pollack, A Lankford, SP Zagars, GK von Eschenbach, AC Geara, FB
Citation: Rh. Liebross et al., Transrectal ultrasound for staging prostate carcinoma prior to radiation therapy - An evaluation based on disease outcome, CANCER, 85(7), 1999, pp. 1577-1585

Authors: Ballo, MT Zagars, GK Pollack, A
Citation: Mt. Ballo et al., Radiation therapy in the management of desmoid tumors, INT J RAD O, 42(5), 1998, pp. 1007-1014
Risultati: 1-16 |